PTDM
Showing 1 - 25 of 29
Post-transplant Diabetes, New Onset Diabetes After Transplant, New Onset Diabetes After Transplantation Trial in London
Completed
- Post-transplant Diabetes Mellitus
- +6 more
- Metformin
- Placebo
-
London, United KingdomRoyal London Hospital, Barts Health NHS Trust
Oct 17, 2022
Cause for Post-Transplant Diabetes Mellitus After Allogeneic
Recruiting
- Diabetes Mellitus
- Cancer
- Oral Glucose Tolerance Test (OGTT)
- +2 more
-
Nashville, TennesseeVanderbilt University Medical Center
Mar 10, 2022
Posttransplant Diabetes Trial in Tuebingen (LCP-tacrolimus, twice-daily tacrolimus)
Recruiting
- Posttransplant Diabetes Mellitus
- LCP-tacrolimus
- twice-daily tacrolimus
-
Tuebingen, GermanyUniversity Hospital Tuebingen
Jun 21, 2022
Kidney Transplant Recipients, Post-transplant Diabetes, Type 2 Diabetes Trial in Toronto (Dapagliflozin 10 MG Oral Tablet,
Recruiting
- Kidney Transplant Recipients
- +2 more
- Dapagliflozin 10 MG Oral Tablet
- Placebo Matching Dapagliflozin Oral Tablet
-
Toronto, Ontario, CanadaRenal Physiology Laboratory
Feb 7, 2022
IBD Trial in Trieste (Infliximab)
Recruiting
- Inflammatory Bowel Diseases
-
Trieste, ItalyInstitute for Maternal and Child Health - IRCCS "Burlo Garofolo"
Mar 18, 2022
HLA-DQA1*05 Genotype in Anti-TNF Treatment With Proactive
Recruiting
- Drug Monitoring
- Inflammatory Bowel Diseases
- Tumor necrosis factor (TNF)-alpha inhibitors
-
Valladolid, SpainHospital Universitario Rio Hortega
Aug 8, 2023
Post Transplantation Diabetes, Obesity, Transplantation of Kidney Trial in Birmingham (Active lifestyle intervention, Control)
Completed
- Post Transplantation Diabetes Mellitus
- +2 more
- Active lifestyle intervention
- Control
-
Birmingham, West Midlands, United KingdomUniversity Hospitals Birmingham NHS Foundation Trust
Jun 10, 2020
Kidney Transplant; Complications, Diabetes Trial (Empagliflozin 25 MG, Linagliptin)
Not yet recruiting
- Kidney Transplant; Complications
- Diabetes Mellitus
- Empagliflozin 25 MG
- Linagliptin
- (no location specified)
Oct 18, 2023
Hypomagnesemia, Kidney Transplantation Trial in Oslo (Mablet 360 mg, Placebo)
Recruiting
- Hypomagnesemia
- Kidney Transplantation
- Mablet 360 mg
- Placebo
-
Oslo, NorwayOslo University Hospital
Sep 27, 2021
Posttransplant Diabetes Trial in Vienna (Empagliflozin 10 mg)
Completed
- Posttransplant Diabetes Mellitus
- Empagliflozin 10 mg
-
Vienna, AustriaDepartment of Internal Medicine III, Division of Nephrology and
May 3, 2019
Kidney Transplant; Complications, Immune Suppression Trial in Oslo (Mycophenolate Mofetil 500 mg Tab, Tacrolimus capsule)
Active, not recruiting
- Kidney Transplant; Complications
- Immune Suppression
- Mycophenolate Mofetil 500 mg Tab
- Tacrolimus capsule
-
Oslo, NorwayOslo University Hospital
Apr 19, 2022
Lung Transplantation, Allografts Trial in Worldwide (Cyclosporine, Mycophenolate mofetil (MMF), Rabbit Anti thymocyte globulin)
Active, not recruiting
- Lung Transplantation
- Allografts
- Cyclosporine
- +4 more
-
Copenhagen, Denmark
- +4 more
Dec 26, 2019
Diabetes, Malignant Tumor Trial in Nashville (assessment of therapy complications, laboratory biomarker analysis)
Terminated
- Diabetes Mellitus
- Malignant Neoplasm
- assessment of therapy complications
- laboratory biomarker analysis
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Jul 15, 2019
Kidney Transplant; Complications Trial (high-protein, carbohydrate-reduced diet, Dutch Nutritional Guidelines)
Not yet recruiting
- Kidney Transplant; Complications
- high-protein, carbohydrate-reduced diet
- Dutch Nutritional Guidelines
- (no location specified)
Jan 5, 2021
Diabetes, Renal Insufficiency, Safety Issues Trial in Oslo (Empagliflozin, Placebo)
Completed
- Diabetes Mellitus
- +2 more
- Empagliflozin
- Placebo
-
Oslo, NorwayOslo University Hospital Rikshospitalet
Mar 13, 2019
Post-transplant Diabetes Trial in Oslo (Glucagon-like peptide-1 (GLP-1), Isotonic saline, Hyperglycemic clamp)
Completed
- Post-transplant Diabetes Mellitus
- Glucagon-like peptide-1 (GLP-1)
- +2 more
-
Oslo, NorwayOslo University Hospital, Rikshospitalet
Mar 30, 2016
Kidney Transplant, Diabetes, Type 2, Diabetic Nephropathy Trial in Stanford (Cyclosporin, Tacrolimus, 'Diabetes Education /
Completed
- Kidney Transplant
- +2 more
- Cyclosporin
- +2 more
-
Stanford, CaliforniaStanford university Hospital and Clinics
Oct 4, 2017
Graft Failure, Death, Acute Rejection of Renal Transplant Trial (Tacrolimus once daily (Advagraf))
Not yet recruiting
- Graft Failure
- +9 more
- Tacrolimus once daily (Advagraf)
- (no location specified)
Aug 11, 2016
Kidney Transplantation, Chronic Kidney Failure Trial in Worldwide (Cyclosporine (CsA), Belatacept LI (less intensive),
Completed
- Kidney Transplantation
- Chronic Kidney Failure
- Cyclosporine (CsA)
- +2 more
-
Birmingham, Alabama
- +104 more
Jul 12, 2016
END STAGE RENAL DISEASE Trial in Guadalajara (ESW group)
Completed
- END STAGE RENAL DISEASE
- ESW group
-
Guadalajara, Jalisco, MexicoUmae Hospital de Especialidades
Dec 26, 2014
Post Transplant Diabetes Trial in Oslo (Tacrolimus)
Completed
- Post Transplant Diabetes Mellitus
-
Oslo, NorwayOslo univeristy hospital, Rikshospitalet
Dec 2, 2014